Methoctramine and hexahydrodifenidol antagonise two muscarinic responses on the rat superior cervical ganglion with opposite selectivity
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 100 (1-3) , 254-258
- https://doi.org/10.1016/0304-3940(89)90694-0
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- p-fluoro-hexahydro-sila-difenidol: The first M2β-selective muscarinic antagonistEuropean Journal of Pharmacology, 1988
- M1 and M2 receptors mediate different effects on synaptically evoked potentials of the rat superior cervical ganglionNeuroscience Letters, 1988
- Methoctramine reveals heterogeneity of M2 muscarinic receptors in longitudinal ileal smooth muscle membranesEuropean Journal of Pharmacology, 1988
- Pharmacological differences between two muscarinic responses of the rat superior cervical ganglion in vitroBritish Journal of Pharmacology, 1987
- MUSCARINIC RECEPTOR SUBTYPES: A CRITIQUE OF THE CURRENT CLASSIFICATION AND A PROPOSAL FOR A WORKING NOMENCLATUREJournal of Autonomic Pharmacology, 1986
- Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- ANTAGONIST DISCRIMINATION BETWEEN GANGLIONIC AND ILEAL MUSCARINIC RECEPTORSBritish Journal of Pharmacology, 1980
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980
- THE PHARMACOLOGY OF FLAXEDIL, WITH OBSERVATIONS ON CERTAIN ANALOGSAnnals of the New York Academy of Sciences, 1951